Your browser doesn't support javascript.
loading
Thymic lymphomas in mice with a truncating mutation in Brca2.
Friedman, L S; Thistlethwaite, F C; Patel, K J; Yu, V P; Lee, H; Venkitaraman, A R; Abel, K J; Carlton, M B; Hunter, S M; Colledge, W H; Evans, M J; Ponder, B A.
Afiliação
  • Friedman LS; Cancer Research Campaign, Human Cancer Genetics Research Group, Cambridge University, Addenbrooke's Hospital, United Kingdom.
Cancer Res ; 58(7): 1338-43, 1998 Apr 01.
Article em En | MEDLINE | ID: mdl-9537225
Inherited mutations in the BRCA2 gene predispose women to breast and ovarian cancer. We created a mutation in the mouse Brca2 gene that terminates translation in exon 11 at 45% of the normal transcript length. Ninety % of Brca2(tm1Cam) homozygous mutant mice die prenatally or perinatally. The location of the Brca2(tm1Cam) mutation differs from those reported previously, and this phenotype suggests a correlation with genotype analogous to that previously reported in humans. Although heterozygote mice have remained free of tumors for 10 months, Brca2(tm1Cam) homozygous mutants that survived to adulthood died with thymic lymphomas between 12 and 14 weeks of age.
Assuntos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Timo / Fatores de Transcrição / Linfoma / Mutação / Proteínas de Neoplasias Limite: Animals / Humans Idioma: En Revista: Cancer Res Ano de publicação: 1998 Tipo de documento: Article País de afiliação: Reino Unido
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Timo / Fatores de Transcrição / Linfoma / Mutação / Proteínas de Neoplasias Limite: Animals / Humans Idioma: En Revista: Cancer Res Ano de publicação: 1998 Tipo de documento: Article País de afiliação: Reino Unido